Document Detail


In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to <5 copies per milliliter, with a half-life of 6 months.
MedLine Citation:
PMID:  12525664     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Three of five virally suppressed human immunodeficiency virus type I (HIV-1)-infected patients treated with highly active antiretroviral therapy and followed intensively with a supersensitive reverse transcriptase PCR assay with a lower limit of quantitation of 5 copies/ml showed statistically significant viral load decays below 50 copies/ml, with half-lives of 5 to 8 months and a mean of 6 months. This range of half-lives is consistent with the estimated half-life of the latent HIV-1 reservoir in the peripheral blood. Those patients without decay of viral load in plasma may have significant cryptic HIV-1 residual replication.
Authors:
Michele Di Mascio; Geethanjali Dornadula; Hui Zhang; Julie Sullivan; Yan Xu; Joseph Kulkosky; Roger J Pomerantz; Alan S Perelson
Related Documents :
8170964 - A rev-inducible mutant gag gene stably transferred into t lymphocytes: an approach to g...
9071434 - Dynamics of the hiv-1 subtype distribution in the swedish hiv-1 epidemic during the per...
11336554 - Evolution of azt resistance in hiv-1: the 41-70 intermediate that is not observed in vi...
15143464 - Prospective analyses of hiv-1-specific proliferative responses, recall antigen prolifer...
8170964 - A rev-inducible mutant gag gene stably transferred into t lymphocytes: an approach to g...
22291694 - Trim5α and species tropism of hiv/siv.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of virology     Volume:  77     ISSN:  0022-538X     ISO Abbreviation:  J. Virol.     Publication Date:  2003 Feb 
Date Detail:
Created Date:  2003-01-14     Completed Date:  2003-02-11     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  0113724     Medline TA:  J Virol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2271-5     Citation Subset:  IM    
Affiliation:
Theoretical Division, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acquired Immunodeficiency Syndrome / drug therapy*,  virology
Antiretroviral Therapy, Highly Active*
CD4-Positive T-Lymphocytes / virology
HIV-1 / drug effects*
Half-Life
Humans
RNA, Viral / blood*
Regression Analysis
Reverse Transcriptase Polymerase Chain Reaction
Viral Load
Grant Support
ID/Acronym/Agency:
AI28433/AI/NIAID NIH HHS; AI46289/AI/NIAID NIH HHS; RR06555/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/RNA, Viral
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fine mapping of a cis-acting sequence element in yellow fever virus RNA that is required for RNA rep...
Next Document:  Protein phosphatase 2A enhances activation of human immunodeficiency virus type 1 by phorbol myrista...